• 750 Citations
  • 11 h-Index
If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Bosio is currently a Research Fellow and Laboratory Head in the Centre for Clinical Research in Emergency Medicine (CCREM) (since September 9, 2015). She is a key member of this unit, contributing and participating in all aspects of the projects being undertaken by the CCREM. Dr Bosio has extensive expertise in Immunology, which has facilitated her work in transplantation, diabetes, stem cells and cancer. She spent 6 years in Italy as a post-doctoral scientist working in the field of xenotransplantation, contributing to a number of different xenotransplantation research projects, as well as clinical studies investigating antibody mediated rejection, while focusing on the assessment of neonatal porcine islets as an alternative tissue source for transplantation for type I diabetes. Following her return to Australia, she joined the Centre for Diabetes Research, investigating hES cells as an islet progenitor cell source for type I diabetes. Following career interruption for maternity and parental reasons (2011-2014), Dr Bosio returned to research part-time before accepting the position within CCREM. The current focus of work within CCREM includes the most significant causes of presentation to the Emergency Department including Sepsis, Stroke, Trauma and Anaphylaxis. In addition to managing CCREM projects, she is also contributing to an NHMRC CRE with the University of Newcastle investigating Translational Venom and Antivenom Research on behalf of CCREM.

Roles and responsibilities

Laboratory Head, Centre for Clinical Research in Emergency Medicine, Royal Perth Hospital and UWA/Harry Perkins Institute for Medical Research

Current projects

2018: Royal Perth Hospital Medical Research Foundation; The role of Resistin in endothelial cell activation in human sepsis.

2017-2020: Australasian College for Emergency Medicine: Sophie Lewis Fellowship. Does the early microRNA profile of cardiac arrest have prognostic potential?

2016-2020: National Health and Medical Research Council Centre for Research Excellence; Translational Venom and Antivenom Research.

2018: Translational Australian Clinical Toxicology (TACT) Program. Development of a 3D in vitro human cell culture system to investigate the mechanism of sudden collapse following snakebite envenoming.

2018: UWA Research Collaboration Award. Investigating the role of the endothelium in the pathogenesis of sepsis.

Teaching overview

Lecturer for:

IMED2003: Essentials of Research in the Health 

PATH2220: Introduction to Human Disease

MICR03305: Immunobiology and Immune Diseases

Currently providing academic teaching support for:

IMED2001: Body Defences

IMED1004: Health and Society

Research interests




Biomarker analyses



Fluent English and Italian

Education/Academic qualification

Immunology, PhD, The University of Western Australia

30 Mar 199830 Apr 2022

Microbiology/Molecular Biology, BSc (Hons), The University of Western Australia

28 Feb 19944 Dec 1997

External positions

Sessional Academic, Edith Cowan University

1 Jul 201431 Dec 2017


  • Emergency medicine
  • Immunology
  • Anaphylaxis
  • Sepsis
  • Biomarkers
  • Critical Illness
  • mechanisms of disease

Fingerprint Dive into the research topics where Erika Bosio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Glycocalyx Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Anaphylaxis Medicine & Life Sciences
Sepsis Medicine & Life Sciences
Neutrophil Activation Medicine & Life Sciences
Syndecan-1 Medicine & Life Sciences
Hemorrhagic Shock Medicine & Life Sciences
Tryptases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 750 Citations
  • 11 h-Index
  • 21 Article
  • 4 Review article
  • 2 Abstract/Meeting Abstract
Hospital Emergency Service
Randomized Controlled Trials
1 Citation (Scopus)

Evaluation of biomarkers of kidney injury following 4% succinylated gelatin and 6% hydroxyethyl starch 130/0.4 administration in a canine hemorrhagic shock model

Boyd, C. J., Raisis, A. L., Cianciolo, R., Bosio, E., Hosgood, G., Nabity, M., Mori, T., Barden, A., Sharp, C. R. & Smart, L., 14 Feb 2019, In : Journal of Veterinary Emergency and Critical Care. 29, 2, p. 132-142

Research output: Contribution to journalArticle

Hydroxyethyl Starch Derivatives
Hemorrhagic Shock

Platelet activation pathways are disrupted during acute anaphylaxis in humans

McGrath, F., Woo, A., Fatovich, D., Arendts, G. & Bosio, E., Sep 2019, In : Internal Medicine Journal. 49, p. 17-17 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

5 Citations (Scopus)
Respiratory Insufficiency
7 Citations (Scopus)

Large-Volume Crystalloid Fluid Is Associated with Increased Hyaluronan Shedding and Inflammation in a Canine Hemorrhagic Shock Model

Smart, L., Boyd, C. J., Claus, M. A., Bosio, E., Hosgood, G. & Raisis, A., Aug 2018, In : Inflammation. 41, 4, p. 1515-1523 9 p.

Research output: Contribution to journalArticle

Hemorrhagic Shock
Hyaluronic Acid

Projects 2011 2019